Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

FDA clears Gore abdominal aortic aneurysm device

WL Gore & Associates has received the US Food and Drug Administration (FDA) approval for Gore C3 Delivery System, which is used to deploy the Gore Excluder AAA Endoprosthesis as minimally invasive treatment for patients with abdominal aortic aneurysm (AAA).

The GORE C3 Delivery System allows physicians and interventionalists to reposition the Gore Excluder Device before the final release of the delivery catheter.

The deployment control of the system provides the physician with increased confidence in treating challenging anatomies and also offers cannulation options.

Gore Aortic Business Unit leader David Abeyta said that the Gore C3 Delivery System for the Gore Excluder Device has shown a high level of performance and has demonstrated that it will provide physicians with added confidence and control during endovascular procedures.